期刊
EXPERT REVIEW OF VACCINES
卷 8, 期 11, 页码 1565-1573出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.09.121
关键词
HBcAg; HBV subunit vaccine platform; virus-like particle; WHcAg
类别
资金
- NIAID NIH HHS [R43 AI072785, R01 AI049730-08, R43 AI072785-02, R01 AI049730, R01 AI020720, R01 AI020720-27] Funding Source: Medline
The first virus-like particle to be tested for use as a vaccine carrier was based on the hepatitis B virus nucleocapsid protein. This viral subunit, while not infectious on its own, is a 36-nm particle that is highly immunogenic during a natural infection. The self-assembly and high degree of immunogenicity is maintained when expressed as a recombinant protein and, moreover, can confer a high degree of immunogenicity on foreign antigens linked to the particle, either chemically or genetically. This review describes the current state of the hepadnaviral core protein as a vaccine carrier.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据